Cargando…

Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment

BACKGROUND: In view of the potential immunosuppressive and regenerative properties of mesenchymal stem cells (MSC), we investigated whether transplantation of adipose tissue-derived stem cells (ASC) could be used to control the granulomatous reaction in the liver of mice infected with Schistosoma ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda, Vitor Hugo Simões, Gomes, Talita Rocha, Eller, Dirli Emerick, Ferraz, Lorena de Cássia Neres, Chaves, Ana Thereza, Bicalho, Kelly Alves, Silva, Carlos Eduardo Calzavara, Birbrair, Alexander, Pascoal Xavier, Marcelo Antônio, de Goes, Alfredo Miranda, Corrêa-Oliveira, Rodrigo, Alves, Érica Alessandra Rocha, Bozzi, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480869/ https://www.ncbi.nlm.nih.gov/pubmed/32853206 http://dx.doi.org/10.1371/journal.pntd.0008635

Ejemplares similares

Anaphylactic reaction to praziquantel following schistosomiasis treatment
por: Vasconcelos, Géssica Almeida, et al.
Publicado: (2023)

Praziquantel for the treatment of schistosomiasis during human pregnancy
por: Friedman, Jennifer F, et al.
Publicado: (2018)

Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis
por: Fukuchi, Takahiko, et al.
Publicado: (2019)

Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis
por: Alwan, Sevan N., et al.
Publicado: (2023)

Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy
por: Silveira-Lemos, Denise, et al.
Publicado: (2013)

Human Schistosomiasis Resistance to Praziquantel in China: Should We Be Worried?
por: Seto, Edmund Y. W., et al.
Publicado: (2011)

Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni
por: HEGAZY, Laila Abdel Moniem, et al.
Publicado: (2018)

Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis Treatment
por: Meyer, Thorsten, et al.
Publicado: (2009)

Performance and Safety of Praziquantel for Treatment of Intestinal Schistosomiasis in Infants and Preschool Children
por: Sousa-Figueiredo, José C., et al.
Publicado: (2012)

Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel
por: Walker, Joseph W., et al.
Publicado: (2020)

Authors' Response to “Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis”
por: Koizumi, Yohei, et al.
Publicado: (2019)

The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review
por: Niu, Xuehua, et al.
Publicado: (2022)

Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
por: Holtfreter, Martha C., et al.
Publicado: (2023)

The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models
por: Paulino, Érica Tex, et al.
Publicado: (2022)

Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel
por: Yepes, Edward, et al.
Publicado: (2015)

Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment
por: Albertini, Beatrice, et al.
Publicado: (2019)

Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
por: Bergquist, Robert, et al.
Publicado: (2017)

Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
por: Pearson, Mark S., et al.
Publicado: (2021)

Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
por: Opio, Christopher Kenneth, et al.
Publicado: (2020)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
por: Zhou, Yi-biao, et al.
Publicado: (2011)

Development of the PraziCalc mobile device-app to calculate praziquantel dosage in the treatment of schistosomiasis
por: Viana, Agostinho Gonçalves, et al.
Publicado: (2018)

Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment
por: Melkus, Michael W., et al.
Publicado: (2020)

Parasitological Observation in Schoolchildren with Urogenital Schistosomiasis Following Treatment with Three Different Brands of Praziquantel
por: Jin, Yan, et al.
Publicado: (2020)

Efficacy of a low‐dose praziquantel and fenbendazole protocol in the treatment of asymptomatic schistosomiasis in dogs
por: Cridge, Harry, et al.
Publicado: (2021)

Efficacy of Praziquantel for the Treatment of Human Schistosomiasis in Ethiopia: A Systematic Review and Meta-Analysis
por: Hailegebriel, Tamirat, et al.
Publicado: (2021)

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

Ureteric obstruction secondary to schistosomiasis 2 years after praziquantel therapy: a case report
por: Olajide, Abimbola Olaniyi, et al.
Publicado: (2012)

Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal
por: Senghor, Bruno, et al.
Publicado: (2016)

Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis
por: Bergquist, Robert, et al.
Publicado: (2018)

437. Spatial Distribution of Schistosomiasis After Repeated Praziquantel Treatments in a Rural Community in Brazil
por: Terashima, Rafael Ponce, et al.
Publicado: (2018)

Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: A randomized controlled trial
por: Wang, Xin-Yao, et al.
Publicado: (2019)

Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
por: Eissa, Maha M., et al.
Publicado: (2020)

In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis
por: Fang, Huilong, et al.
Publicado: (2021)

Cytokine Response Profiles of School-Aged Children Infected with Schistosomiasis before and after Praziquantel Treatment
por: Okonjo, Edward, et al.
Publicado: (2021)

Bioorganometallic Compounds as Novel Drug Targets against Schistosomiasis in Sub-Saharan Africa: An alternative to Praziquantel?
por: Ndamse, Cuma Cumisa, et al.
Publicado: (2022)

Utility of Repeated Praziquantel Dosing in the Treatment of Schistosomiasis in High-Risk Communities in Africa: A Systematic Review
por: King, Charles H., et al.
Publicado: (2011)

Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis
por: Liu, Rong, et al.
Publicado: (2011)

Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey
por: Knopp, Stefanie, et al.
Publicado: (2016)

Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children
por: Wami, Welcome M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9oqb98bcnf9cglelj6454sv13d